A consortium of investors has led a series-C financing of mtm laboratories. The round will enable the company to fund the clinical development and commercialisation of its proprietary diagnostic and screening devices in the field of cervical cancer. mtm is based in Heidelberg and has developed a number of bio-markers for cervical cancer. It also has operations in Westborough, near Boston.
With SEP's support, Dohop intends to scale up its team and expand its global sales
Exit ends BPE's three-and-a-half-year holding period; the add-on is Stella's second under PAI
Combined group generates revenues of DKK 850m and employs 150 staff across 11 offices in Denmark
Sale process for the medical workwear company saw interest from FSN and Gilde, Mergermarket reported